Live Breaking News & Updates on Bi 0451

Stay updated with breaking news from Bi 0451. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pardes Biosciences Appoints Thomas G. Wiggans to CEO and

Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in chief executive leadership roles with multiple. ....

Pardes Biosciences , Mark Auerbach , Stephen Jasper , Thomasg Wiggans , Pardes Bioscience , Eli Lilly , Tom Wiggans , University Of Kansas , Southern Methodist University , Sangamo Biosciences , Cymabay Therapeutics Inc , Forma Therapeutics Holdings Inc , Board Of Directors Connetics Corporation , Board Of Directors Annexon Inc , Onyx Pharmaceuticals , Cytotherapeutics Inc , Pardes Biosciences Inc , Exchange Commission , Board Of Directors Peplin Inc , Gilmartin Group , Somaxon Pharmaceuticals Inc , Chief Scientific , Strategic Advisor , Chief Executive Officer , Yuri Lopatin , Connetics Corporation ,